MIB2 and melanoma: This is in agreement with previously published data, showing that IM upregulates CXCL8 in keratinocytes, fibroblast, neutrophils and melanoma cells in vitro as well as MIB-2, the murine homologue of CXCL8, in IM-treated mouse skin [6].